Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PTCT will decline by -2.48% over the next 2 Weeks and hit $71.84 by Wednesday, September 2, 2026. In that time frame, PTCT's share price is expected to range between $68.16 and $75.02.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 2, 2026 | 68.16 | 71.84 | 75.02 |
| Sep 1, 2026 | 69.29 | 72.46 | 75.71 |
| Aug 31, 2026 | 69.43 | 72.46 | 75.88 |
| Aug 28, 2026 | 68.57 | 72.04 | 75.66 |
| Aug 27, 2026 | 70.00 | 73.15 | 76.51 |
| Aug 26, 2026 | 68.92 | 72.34 | 75.67 |
| Aug 25, 2026 | 69.49 | 72.96 | 76.35 |
| Aug 24, 2026 | 69.76 | 72.97 | 76.51 |
| Aug 21, 2026 | 68.83 | 72.54 | 75.90 |
| Aug 20, 2026 | 70.20 | 73.65 | 76.98 |
PTCT shares fell -2.46% in Thursday, August 20, 2026's trading session, dropping from a previous close of $73.67 to move at $71.86. The stock demonstrated notable intraday movement (see PTCT's key stats for a full breakdown), fluctuating between $71.84 and $73.55, a +2.37% trading range. While recent weeks have seen some volatility, PTCT has managed to secure a +1.43% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 1.51M shares changing hands, 782.93K more than the previous session. This amounted to $108.84M in total market activity.
Will PTCT Continue Its Upward Trend?
According to analyst ratings and projections for PTCT, PTC Therapeutics, Inc. shares are anticipated to increase by +4.21%, potentially reaching $75.02 per share by September 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for PTCT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the PTCT stock forecast, now is a good time to buy PTCT stock because its current trading price is +0.03% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on PTCT covering social and institutional perspectives.
PTCT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PTCT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.49% to 44.61%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 48.50%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.42%, maintains a neutral outlook for the long term. Insights into PTCT's shareholder base show how institutional investors are positioning themselves during these momentum shifts
PTC Therapeutics Short-Term Forecasts
PTCT Forecast For Next 5 Days
Our algorithm anticipates PTC Therapeutics (PTCT) stock could hit $73.67 by Aug 27, 2026. This represents a +2.52% fall from today's price, following a -5.83% change over the past five days.
PTCT Forecast For Next 30 Days
Based on analysis of market trends, the outlook for PTC Therapeutics, Inc. (PTCT) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $75.45, which would mean a +5.00% increase from the current price of $71.86. Projections for this period range from a high of $87.19 to a low of $60.36.
PTCT Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for PTC Therapeutics's price over the next three months point to a rise. PTCT stock is expected to peak at $91.66 on Nov 11, 2026 after potentially dipping to $69.49 on Aug 20, 2026. On average, PTCT is likely to trade around $79.03 in the coming 90 days.
PTC Therapeutics Stock Forecast 2025
Based on our predictive models, PTC Therapeutics (PTCT) is expected to trade between $69.49 and $91.66 throughout 2026. This would result in an average price of $80.14, potentially offering investors a +11.52% return from current levels.
PTC Therapeutics, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, PTC Therapeutics, Inc. (PTCT) is positioned to show a strong performance in August 2026. The price is predicted to move between $69.49 and $77.92, settling at an average of $74.16. This could translate to a +3.20% gain.
September 2026
Based on current market signals, PTC Therapeutics, Inc. is projected to trend september 2026. We forecast a trading range from $70.86 to $82.96, with a likely average price of $77.66. Investors could expect a potential return of +8.07%.
October 2026
Our predictive algorithms indicate PTC Therapeutics, Inc. stock may see a shift in October 2026. The expected range spans $74.14–$84.43, with an average target of $79.51. This represents a positive outlook and a possible gain of +10.65%.
November 2026
Analyzing established trends, PTC Therapeutics, Inc. looks set to move in November 2026. Projections place the stock between $77.81 and $91.66, averaging around $83.08. This suggests a +15.61% gain from current levels.
December 2026
Market indicators suggest PTC Therapeutics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $75.93 to $87.24, with a midpoint forecast of $82.50. The stock might deliver a +14.81% gain.
January 2027
Forecasting for January 2027, models estimate that PTC Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $76.10 and $84.61, averaging $80.66. This signals a positive trajectory with potential returns around +12.25%.
February 2027
According to our latest forecast models, PTC Therapeutics, Inc. (PTCT) is positioned to show a strong performance in February 2027. The price is predicted to move between $78.41 and $89.69, settling at an average of $84.95. This could translate to a +18.22% gain.
March 2027
Based on current market signals, PTC Therapeutics, Inc. is projected to trend march 2027. We forecast a trading range from $80.81 to $91.23, with a likely average price of $86.50. Investors could expect a potential return of +20.37%.
April 2027
Our predictive algorithms indicate PTC Therapeutics, Inc. stock may see a shift in April 2027. The expected range spans $84.58–$93.93, with an average target of $89.88. This represents a positive outlook and a possible gain of +25.08%.
May 2027
Analyzing established trends, PTC Therapeutics, Inc. looks set to move in May 2027. Projections place the stock between $83.26 and $94.28, averaging around $89.40. This suggests a +24.41% gain from current levels.
June 2027
Market indicators suggest PTC Therapeutics, Inc. could experience notable changes during June 2027. Prices could fluctuate within $82.70 to $91.47, with a midpoint forecast of $87.61. The stock might deliver a +21.92% gain.
July 2027
Forecasting for July 2027, models estimate that PTC Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $85.32 and $97.30, averaging $91.96. This signals a positive trajectory with potential returns around +27.97%.
August 2027
According to our latest forecast models, PTC Therapeutics, Inc. (PTCT) is positioned to show a strong performance in August 2027. The price is predicted to move between $89.44 and $97.55, settling at an average of $93.27. This could translate to a +29.79% gain.
PTCT's history of dividends and stock splits also plays a role in long-term investor confidence.